Internal Jugular Vein Collapsibility Index as a Predictor of Hypotension

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60+
SponsorAin Shams University

About this trial

The internal jugular vein (IJV) collapsibility index has been proposed as a practical alternative of of the inferior vena cava collapsibility index (IVC-CI), as it is easily accessible using bedside ultrasonography. Several studies have demonstrated a correlation between IJV collapsibility and central venous pressure as well as right atrial pressure.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged ≥ 60 years.

Scheduled for elective laparoscopic colorectal surgeries under general anesthesia.

Disqualifiers

Patients' refusal of procedure or participation in the study.

Severe aortic stenosis, irregular ventricular rhythm (atrial fibrillation or frequent premature ventricular contractions), or any contraindication to perform passive leg raise (PLR).

Trial population

* Patients aged ≥ 60 years. * Scheduled for elective laparoscopic colorectal surgeries under general anesthesia.

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

  • Internal Jugular Vein Collapsibility Index

    Other intervention

    Assessment of internal jugular vein collapsibility index to predict hypotension after the induction of general anesthesia in geriatric patients undergoing laparoscopic colorectal surgeries.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Optimal cut-off value of ultrasound guided Internal Jugular Vein Collapsibility Index (percent) (%) to predict post induction hypotension.

Optimal cut-off value of ultrasound guided Internal Jugular Vein Collapsibility Index (percent) (%) to predict post induction hypotension.

Time frame
The first 15 minutes after induction of general anesthesia.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.